MHH researchers are developing an innovative drug to prevent the rejection of donor skin grafts.

A large multicenter study led by the Department of Neurology at MHH confirms deficits in word fluency and visual information processing.

Imaging technique developed at MHH enables regional imaging of lung function without radiation exposure and breathing stops.

MHH cooperation project PRETTY develops prediction model for individual risk of side effects after stem cell transplantation

The MHH is one of the first institutions in Germany to be allowed to perform a new innovative treatment for hemophilia A and B.

First study to date to investigate the risk of cancer in mosaic RASopathies due to disease-causing variants in the HRAS or KRAS genes shows the…

Biontech vaccine activated for booster vaccination against the current Corona variant JN.1 Production of adapted antibodies

MHH study investigates how effective inhalation with hypertonic saline solution is for incurable respiratory disease PCD.

Lower Saxony research incubator Institute for Biomedical Translation (IBT) supports MHH project Bacta Implants with 770,000 euros.

MHH project aims to bring genetic diagnostics and counselling for relatives of unexpectedly deceased children and adolescents into standard care.